Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Lupin Receives USFDA EIR with VAI Status for Goa Manufacturing Plant

Lupin bags tentative USFDA nod for Raltegravir Tablets for HIV-1 infection

Written By Ruchika Sharma9 Nov 2024 11:00 AM IST

Mumbai: Global pharma major Lupin Limited has announced that the Company has received tentative approval from the United States Food and Drug...

USFDA Approves Johnson and Johnson Blood Cancer Drug Tecvayli-Darzalex Combo

Johnson & Johnson MedTech bags USFDA nod for the Varipulse Pulsed Field Ablation Platform for atrial fibrillation

Written By Ruchika Sharma8 Nov 2024 11:00 AM IST

Irvine: Johnson & Johnson MedTech has announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSE Platform for the...

Boehringer Ingelheims Vetmedin Becomes First USFDA-Approved Drug to Delay Heart Failure in Dogs

Boehringer Ingelheim, Broad Institute of MIT and Harvard to develop treatments for people with mental health conditions

Written By Ruchika Sharma8 Nov 2024 9:00 AM IST

Ingelheim: Boehringer Ingelheim and researchers from the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard have agreed...

Sanofis Sarclisa Gets EMA Nod for Subcutaneous On-Body Injector Version

Sanofi, Regeneron Dupixent approved in EU for young children with eosinophilic esophagitis

Written By Ruchika Sharma7 Nov 2024 3:55 PM IST

Paris: Sanofi has announced that the European Medicines Agency has approved Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE) in...

NCLT Chennai Approves Apollo Hospitals’ Composite Scheme of Arrangement

Apollo Hospitals exceeds Q2 profit forecast on strong demand for healthcare services

Written By Ruchika Sharma7 Nov 2024 11:30 AM IST

Bengaluru: Apollo Hospitals Enterprise exceeded profit expectations for the second quarter, with increased demand for healthcare services driving...

Venus Remedies expands presence in Vietnam with marketing nods for Methotrexate, Cefuroxime, Irinotecan

Venus Remedies expands reach in ASEAN region with Malaysian PIC/S GMP nod for Pre-filled Syringe facility

Written By Ruchika Sharma5 Nov 2024 3:30 PM IST

Mumbai: Venus Remedies Limited, a exporter of generic drugs with presence in more than 80 countries, has received Good Manufacturing...

Dr Reddy gets CDSCO Panel nod for oral semaglutide

Dr Reddy's Labs recalls over 3 lakh bottles of Cinacalcet tablets in US over manufacturing issues

Written By Ruchika Sharma5 Nov 2024 1:30 PM IST

New Delhi: Dr Reddy's Laboratories is recalling over 3.3 lakh bottles of Cinacalcet tablets, a medication used for treatment of high calcium...

Health Ministry Appoints 27 Government Analysts as Medical Device Testing Officers

Natco Pharma names Imtiyaz Basade as Senior Vice President - RAD, Pharma Division, Kothur Unit

Written By Ruchika Sharma5 Nov 2024 11:24 AM IST

Telangana: Natco Pharma has announced that Imtiyaz Basade has been appointed as Senior Vice President - RAD, Pharma Division, Kothur Unit w.e.f....

Shilpa Medicare bags initial authorization for Rotigotine Transdermal Patch from Europe

Shilpa Medicare gets four USFDA observations for Bengaluru facility

Written By Ruchika Sharma4 Nov 2024 3:58 PM IST

Raichur: Shilpa Medicare has announced that the US Food and Drug Administration (USFDA) has issued Form 483 with four observations at the...

Ciplas Lanreotide Supply Partners Greece Plant Gets USFDA OAI Status

USFDA classifies Cipla Goa facility as VAI

Written By Ruchika Sharma4 Nov 2024 11:30 AM IST

Mumbai: Through a recent BSE filing, Cipla has informed that the United States Food and Drug Administration (USFDA) has classified the routine...

Lupin to focus on development of inhalers with near-zero global warming potential propellants

Written By Ruchika Sharma3 Nov 2024 11:00 AM IST

Mumbai: Global pharma major Lupin Limited has announced its focus on formulating respiratory inhalers by incorporating a propellant with...

Merck, Moderna begin Phase 3 Trial of V940 with Keytruda in non small lung cancer

Written By Ruchika Sharma3 Nov 2024 10:00 AM IST

Rahway: Merck, known as MSD outside of the United States and Canada, and Moderna, Inc., announced the initiation of INTerpath-009, a pivotal...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok